Processa Pharmaceuticals to Present at “Zooming with LD Micro” Virtual Investor Event on July 29, 2021 at 12:00 p.m. ET

Rhea-AI Summary

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) will present at the "Zooming with LD Micro" virtual investor event on July 29, 2021, at 12:00 PM ET. Investors can register for the event on the company's website. Processa focuses on developing treatments for unmet medical needs and has a team experienced in over 30 FDA drug approvals. The company emphasizes improving patient survival and quality of life through its innovative products.

HANOVER, MD, July 27, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) announced today that it will be presenting at the upcoming “Zooming with LD Micro” virtual investor event on Thursday, July 29th, 2021 at 12:00 PM ET.

Investors and other individuals may access the virtual presentation by registering here: https://us02web.zoom.us/webinar/register/WN_NUnXZfaETuihigrh1PspxA

About Processa Pharmaceuticals, Inc.

The mission of Processa has been to develop products where existing clinical evidence of efficacy already exists in unmet medical need conditions, medical conditions where patients need treatment options that will improve survival and/or quality of life. The Company has assembled a proven regulatory science development team, management team, and Board of Directors. The Processa development team has been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and 100 FDA meetings. For more information, please visit http://www.processapharma.com.

For More Information:
Michael Floyd
mfloyd@processapharma.com
(301) 651-4256

James Carbonara
Hayden IR
(646) 755-7412
james@haydenir.com

FAQ

When is Processa Pharmaceuticals presenting at the LD Micro event?

Processa Pharmaceuticals will present at the LD Micro event on July 29, 2021, at 12:00 PM ET.

How can I register for the Processa Pharmaceuticals virtual presentation?

You can register for the Processa Pharmaceuticals virtual presentation by visiting their official registration link.

What is the focus of Processa Pharmaceuticals?

Processa Pharmaceuticals focuses on developing products for unmet medical needs, aiming to improve survival and quality of life for patients.

How experienced is Processa Pharmaceuticals' team with FDA drug approvals?

The Processa Pharmaceuticals team has been involved in over 30 FDA drug approvals and 100 meetings with the FDA.

What stock symbol represents Processa Pharmaceuticals?

The stock symbol for Processa Pharmaceuticals is PCSA.